Philips, the manufacturer behind the recalled sleep apnea devices, is set to suspend their sales in the United States.

On January 29, 2024 at 3:11 PM EST, the most-Googled questions about sleep were revealed by MoneyWatch. This comes after the company behind a global recall of sleep apnea machines, Philips, announced a tentative agreement with regulators to stop selling the devices in the U.S. The recall, which affects over 5 million machines, was due to risks of the internal foam breaking down and causing users to inhale tiny particles while sleeping. The company has set aside $393 million to deal with expenses needed to comply with the agreement, which has not yet been finalized and will need to be approved by a U.S. judge. Philips has promised to prioritize safety and quality in their future actions. The FDA has warned patients about the potential health risks of using the affected machines, including headaches, asthma, and allergic reactions. In rare cases, the machines can also overheat and cause fires. The FDA has ordered Philips to improve their outreach to customers about the recall, as many were unaware of the issue. Customers have reported delays in obtaining refunds or new devices from the company. The affected machines, called continuous positive airway pressure (CPAP) machines, are used to treat sleep apnea, a condition that can lead to dangerous drowsiness and increased risk of heart attack. However, this announcement does not resolve the 675 personal injury lawsuits filed against the company over the devices. These lawsuits have been consolidated in a federal court in Pennsylvania.  

Share This Article
Leave a comment